Published in Biochim Biophys Acta on August 09, 1976
The isolation and partial characterization of low-molecular-weight phosphorylated component of the non-histone proteins of mouse nuclei. Biochem J (1978) 0.79
Differential expression of genes and proteins between electric organ and skeletal muscle in the mormyrid electric fish Brienomyrus brachyistius. J Exp Biol (2012) 0.79
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Proc Natl Acad Sci U S A (1995) 1.88
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci (1996) 1.74
Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem (1999) 1.73
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci (1996) 1.61
Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer (2000) 1.60
Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res (1997) 1.52
Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem (1998) 1.51
Trimethyllysine and protein function. Effect of methylation and mutagenesis of lysine 115 of calmodulin on NAD kinase activation. J Biol Chem (1986) 1.49
Opiate receptor binding affected differentially by opiates and opioid peptides. Eur J Pharmacol (1979) 1.45
Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Ther (2000) 1.38
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol (1997) 1.36
Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther (1997) 1.36
Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther (1998) 1.30
Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci (2000) 1.22
Hyperphenylalaninemia: disaggregation of brain polyribosomes in young rats. Science (1970) 1.22
Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science (1980) 1.21
Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol (2000) 1.18
The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide. Eur J Pharmacol (1978) 1.18
Aminoalkylindoles: actions on specific G-protein-linked receptors. J Pharmacol Exp Ther (1991) 1.14
Calmodulin N-methyltransferase. Partial purification and characterization. J Biol Chem (1986) 1.10
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol (1996) 1.08
Differential regulation by guanine nucleotides or opiate agonist and antagonist receptor interactions. J Neurochem (1980) 1.08
Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein. J Biol Chem (1983) 1.07
Purification of a calcium-binding phosphoprotein from pig brain. J Biol Chem (1972) 1.06
The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis (1998) 1.05
mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol (2001) 1.05
Scanning and transmission electron microscopy of the rat kidney. Am J Anat (1974) 1.03
Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells. Br J Cancer (1999) 1.03
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes. Life Sci (1996) 1.02
Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels (1993) 1.01
Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors. Life Sci (1978) 1.01
Immunohistochemical mapping of enkephalin containing cell bodies, fibers and nerve terminals in the brain stem of the rat. Brain Res (1979) 1.01
Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res (1993) 1.00
Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. J Pharmacol Exp Ther (1980) 0.99
Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. J Comp Neurol (1997) 0.98
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Brain Res (1997) 0.97
Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain. Neuroscience (1999) 0.97
Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus. Br J Pharmacol (2000) 0.96
Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Brain Res Mol Brain Res (1998) 0.95
Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors. J Neurochem (1998) 0.94
Synthesis of 2 beta-acyl-3 beta-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J Med Chem (1994) 0.94
Glutathione S-transferase isoenzymes in rat brain neurons and glia. J Neurosci (1993) 0.94
Scanning and transmission electron microscopy of mercuric chloride-induced acute tubular necrosis in rat kidney. Virchows Arch B Cell Pathol (1975) 0.94
Isolation and purification of calcium-binding protein from electroplax of Electrophorus electricus. Biochim Biophys Acta (1975) 0.93
Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine. Neuropharmacology (2000) 0.92
Translocation of nascent non-signal sequence protein in heated Escherichia coli. J Biol Chem (1986) 0.92
The analgesic tropane analogue (+/-)-SM 21 has a high affinity for sigma2 receptors. Life Sci (1999) 0.91
Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord. Brain Res (2001) 0.91
Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTP gamma S binding in rat brain. Neuroreport (1996) 0.90
Effects of lead on rat kidney and liver: GST expression and oxidative stress. Toxicology (1998) 0.89
Calcium-binding phosphoprotein of pig brain: effects of cations on the calcium binding. J Neurochem (1972) 0.89
Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate. J Comp Neurol (2001) 0.89
The reinforcing and discriminative stimulus effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther (1997) 0.89
Induction of differentiation increases Met5-enkephalin and Leu5-enkephalin content in NG108-15 hybrid cells: an immunocytochemical and biochemical analysis. J Neurosci (1983) 0.88
Opiate receptors and opioid peptides. Annu Rev Neurosci (1979) 0.88
Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Biochem Pharmacol (2000) 0.88
Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. J Neurochem (1999) 0.87
Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone. Eur J Pharmacol (2000) 0.87
Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor. Biochem Pharmacol (1995) 0.87
Polyribosome disaggregation and cell-free protein synthesis in preparations from cerebral cortex of hyperphenylalaninemic rats. J Neurochem (1971) 0.87
Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. J Neurochem (1997) 0.87
Enzymatic methylation of calmodulin in rat brain cytosol. J Biol Chem (1980) 0.87
Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J Pharmacol Exp Ther (1995) 0.86
Posttranslational modification of calmodulin in rat brain and pituitary. J Neurochem (1986) 0.86
Posttranslational modification of calmodulin. Methods Enzymol (1983) 0.86
Opioid peptides: differentiation by radioimmunoassay and radioreceptor assay. Brain Res (1977) 0.86
In vitro autoradiographic localization of 5-HT1A receptor-activated G-proteins in the rat brain. Brain Res Bull (1997) 0.86
Ibogaine possesses a selective affinity for sigma 2 receptors. Life Sci (1995) 0.86
Calmodulin N-methyltransferase. Kinetics, mechanism, and inhibitors. J Biol Chem (1996) 0.86
Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane. Cancer Res (1991) 0.85
Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex. J Pharmacol Exp Ther (2001) 0.84
Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol (1993) 0.84
Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes. Biochem Pharmacol (1993) 0.84
Regional protein alterations in rat kidneys induced by lead exposure. Electrophoresis (1999) 0.84
Regional, cellular and subcellular distribution of calcium-activated cyclic nucleotide phosphodiesterase and calcium-dependent regulator in porcine brain. J Neurochem (1977) 0.84
(3H) Opiate binding: anomalous properties in kidney and liver membranes. Mol Pharmacol (1978) 0.83
Maturation of cochlear glutathione-S-transferases correlates with the end of the sensitive period for ototoxicity. Hear Res (1999) 0.83
Differential expression of cytosolic proteins in the rat kidney cortex and medulla: preliminary proteomics. Electrophoresis (1998) 0.83
Alterations of the renal papilla during mercuric chloride-induced acute tubular necrosis. Lab Invest (1975) 0.83
Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets. Biochim Biophys Acta (1984) 0.83
Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands. J Med Chem (1998) 0.83
Angiotensin effects on calcium and steroidogenesis in adrenal glomerulosa cells. Endocrinology (1985) 0.82
Synthesis of 3 beta-aryl-8-azabicyclo[3.2.1]octanes with high binding affinities and selectivities for the serotonin transporter site. J Med Chem (1996) 0.82
Carboxylmethylation of calmodulin in cultured pituitary cells. J Neurochem (1987) 0.82
Modification of guanine nucleotide-regulatory components in brain membranes. II. Relationship of guanosine 5'-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase. J Neurosci (1984) 0.81
Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain. J Pharmacol Exp Ther (2000) 0.81
Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. Life Sci (1995) 0.81
Fluorine-18-labeled tropane analogs for PET imaging studies of the dopamine transporter. Synapse (2000) 0.81
Effects of lead administration on developing rat kidney. II. Functional, morphologic, and immunohistochemical studies. Toxicol Appl Pharmacol (1995) 0.81
Effects of lead administration on developing rat kidney. I. Glutathione S-transferase isoenzymes. Toxicol Appl Pharmacol (1995) 0.81
Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes. J Neurochem (1994) 0.81
Chemical and metabolic characteristics of synaptic complexes from brain isolated by zonal centrifugation in a cesium chloride gradient. J Biol Chem (1971) 0.80
Proteomic analysis of simulated occupational jet fuel exposure in the lung. Electrophoresis (1999) 0.80
Characterization of methylation of rat liver cytosolic glutathione S-transferases by using reverse-phase h.p.l.c. and chromatofocusing. Biochem J (1990) 0.80
Characterization of [3H]guanine nucleotide binding sites in brain membranes. J Neurochem (1980) 0.80
Identification of glutathione S-transferase as a substrate and glutathione as an inhibitor of in vitro calmodulin-stimulated protein methylation in rat liver cytosol. Biochem Biophys Res Commun (1988) 0.80
Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur J Pharmacol (1993) 0.80